immune-checkpoint

Documents about immune-checkpoint

• Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer.#915587ClinicalTrials.gov
• Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors#883751ClinicalTrials.gov
• Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge#414799Europe PMC
• Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors#848221ClinicalTrials.gov
• Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients#28340ClinicalTrials.gov
• OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure#226273ClinicalTrials.gov
• Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma#249609ClinicalTrials.gov
• Reprogramming tumour-associated macrophages from immune suppressive to inflammatory state by Checkpoint kinase 1 inhibitor combination treatment#279383bioRxiv / medRxiv
• VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer#290993ClinicalTrials.gov
• Immune checkpoint inhibitor-associated myocarditis: a novel risk score#370841HAL (France)
• Age and CMV are not associated with clinical or immunological response to immune checkpoint blockade#651094bioRxiv / medRxiv
• Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors#804531ClinicalTrials.gov
• TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC#843144ClinicalTrials.gov
• Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients#869553ClinicalTrials.gov
• Immune Checkpoint Inhibitor In High Risk Oral Premalignant Lesions#896857ClinicalTrials.gov
• Non-tuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review#988065IRIS
• Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real‐world study#239056HAL (France)
• Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer#856533ClinicalTrials.gov
• Highly activated CD4+ T regulatory cells associated with non- responders to immune-checkpoint inhibitors in metastatic melanoma#123343Europe PMC
• Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas#158228ClinicalTrials.gov
• Immune System Regulation: Inhibitory Checkpoint Receptors#169458ODU Digital Commons
• Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cells.#174617NCBI PubMed Central
• Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced Dermatitis#261504ClinicalTrials.gov
• CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC#283030ClinicalTrials.gov
• A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability#326109HAL (France)
• Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC#411392ClinicalTrials.gov
• Reprogramming the Tumor Microenvironment in Desmoplastic Tumors to Potentiate Cancer Immunotherapy#643416Harvard DASH
• Reprogramming the Tumor Microenvironment in Desmoplastic Tumors to Potentiate Cancer Immunotherapy#643468Harvard DASH
• Observational Cohort Study of Chronic Viral Infection in the Central Nervous System#813886ClinicalTrials.gov
• Surgery Following Immune Checkpoint Inhibitions for Controlled Disease in Recurrent or Metastatic dMMR/MSI-H Colorectal Cancer#839973ClinicalTrials.gov
• Microbiome Immunotherapy Toxicity and Response Evaluation#843036ClinicalTrials.gov
• The inhibitory effect of hepatic cancer energy metabolism on immune checkpoint therapy: perspectives from single-cell multi-omics analysis.#143246NCBI PubMed Central
• Reinvigorating COTL1(high) NK cells via GITR signalling overcomes immune checkpoint blockade resistance in tsMHC-I-impaired tumours.#193432NCBI PubMed Central
• Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS.#199204NCBI PubMed Central
• Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors#303750ClinicalTrials.gov
• Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases#311895HAL (France)
• Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer#373585ClinicalTrials.gov
• The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy#426763ClinicalTrials.gov
• Cancer-related fatigue during treatment with neoadjuvant and/or adjuvant immune checkpoint inhibitors: a systematic review and meta-analysis.#437127NCBI PubMed Central
• LKB1 dictates sensitivity to immunotherapy through Skp2-mediated ubiquitination of immune checkpoint proteins in HCC with python analysis.#465063NCBI PubMed Central
• Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr#628522ClinicalTrials.gov
• The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies#633718ClinicalTrials.gov
• Global research trends in fecal microbiota transplantation combined with immune checkpoint inhibitors for cancer immunotherapy: a bibliometric analysis.#685707NCBI PubMed Central
• cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors#834443ClinicalTrials.gov
• Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer#845458ClinicalTrials.gov
• Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma#898130ClinicalTrials.gov
• Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma#910805ClinicalTrials.gov
• Ago2 loss restores sensitivity to immune checkpoint inhibitors in immunorefractory lung cancer#923048HAL (France)
• Data Sheet 1_Tumor-intrinsic immune-genetic dynamics identify RNASE1 as an immune-evasion-associated biomarker and predictor of checkpoint blockade response in gastric adenocarcinoma.docx#322249Figshare
• Invalidation des immune checkpoints PD-1 et TIGIT dans des lymphocytes T CD8+ spécifiques de tumeur : conséquences fonctionnelles et utilisation en immunothérapie#268566HAL (France)